Special Organic Chemistry Seminar
Noyes 153 (J. Holmes Sturdivant Lecture Hall)
The Road to ABT-869, an Orally Active Multi-targeted Receptor Tyrosine Kinase Inhibitor
Michael R. Michaelides,
Dr.,
Global Pharmaceutical Research & Development,
Abbott Laboratories,
"The Road to ABT-869, an Orally Active Multi-targeted Receptor Tyrosine Kinase Inhibitor," Michael R. Michaelides, Abbott Laboratories.
For more information, please contact Arleen (Lynne) Martinez by phone at 4004 or by email at [email protected].
Event Series
Special Organic Chemistry Seminar Series